Viewing Study NCT03309605


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-02-10 @ 10:31 PM
Study NCT ID: NCT03309605
Status: COMPLETED
Last Update Posted: 2021-03-16
First Post: 2017-10-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 1 Study of ELX-02 in Healthy Adult Subjects
Sponsor: Eloxx Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Genetic Disease View
None Nonsense Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Translational read through View